Privi Speciality Chemicals (PRIVISCL) investor relations material

Executive summary

• Delivered robust performance in Q3 and nine months FY26, achieving 24% year-over-year revenue growth driven by diversified product mix, operational efficiencies, and resilience amid global trade uncertainties and geopolitical headwinds.

• Strategic three-phase expansion roadmap and focus on innovation, sustainability, and capacity expansion to increase capacity by 55% and broaden specialty product portfolio over the next 2-3 years.

• Amalgamation of subsidiaries underway to unlock synergies and enhance operational efficiency.

• Strengthening trade ties with the US and EU, and favorable tariff changes, position the company for export-led growth.

• Unaudited consolidated and standalone financial results for the quarter and nine months ended December 31, 2025, were reviewed and approved on February 9, 2026, with statutory auditors expressing an unmodified review conclusion.

Financial highlights

• Q3 FY26 consolidated revenue grew 24% year-over-year to INR 611.15 crore (₹60,464.10 lakhs); nine-month revenue at INR 1,857 crore, also up 24%.

• Q3 EBITDA rose 37% year-over-year to INR 158 crore, with a margin of 25.83%; Q3 PAT at INR 82 crore (up 76% YoY); nine-month PAT at INR 233.84 crore, up 94% year-over-year.

• Nine-month EBITDA at INR 481 crore, up 47% year-over-year, with a margin of 25.9%.

• Basic and diluted EPS (consolidated) for Q3 FY26 was ₹19.97, up from ₹11.38 in Q3 FY25; nine-month EPS at ₹59.86, up from ₹30.84.

• One-time expense of Rs. 389.96 lakh due to new labor legislation in Nov 2025.

Outlook and guidance

• Targeting INR 5,000 crore revenue and INR 1,000 crore EBITDA within 3-4 years, with EBITDA margin guidance above 20% and management aiming to sustain 22-25% margins.

• Volume growth expected at 7-15% in the coming year, with value growth likely to outpace volume due to value-added products.

• Capacity utilization expected to remain around 90% as new capacity comes online.

• Continued investments in green chemistry, biotechnology, and digital transformation.

• The company continues to monitor the impact of new labour codes and will recognize adjustments as needed when further clarifications are issued.